Laura Hayman to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Laura Hayman has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.687
-
Hayman LL, Himmelfarb CD. Statins and Cardiovascular Health: Controversy, Consensus, and Clinical Judgment. J Cardiovasc Nurs. 2017 Mar/Apr; 32(2):90-92.
Score: 0.475
-
Hughes S, Hayman LL. A new era in statin therapy. J Cardiovasc Nurs. 2004 Jul-Aug; 19(4):287-9.
Score: 0.197
-
McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, Hayman LL, Daniels SR. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007 Apr 10; 115(14):1948-67.
Score: 0.015